In-Depth Insights into the Crohn’s Disease Treatment Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the crohn’s disease treatment market grown in recent years?
The market size for Crohn’s disease treatment has significantly expanded in the past few years. The market will see an increase from $12.45 billion in 2024 to $13.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.2%. The escalation observed historically is a result of the rising prevalence of the disease, progress in diagnostic methods, the adoption of biological treatments, patient awareness, education, as well as clinical research and development.
How is the crohn’s disease treatment market size expected to evolve during the forecast period?
Anticipations are high for the Crohn’s disease treatment market as it’s expected to experience vigorous expansion in the upcoming years. The projections suggest that it will reach a value of “$17.67 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this significant growth during the forecast period encompass advances in personalized medicine, the expansion of biologics market, utilization of progressive treatment frameworks, increased investment in healthcare, and collective research initiatives. The period is likely to observe some major trends such as the use of telemedicine for patient management, exploratory research on immune modulation strategies, the introduction of patient-centered care structures, and the incorporation of digital health technologies.
Get your crohn’s disease treatment market report here!
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Which key drivers are propelling the crohn’s disease treatment market’s growth?
The escalation in the occurrence of inflammatory bowel disorders is set to drive the expansion of the market for Crohn’s disease treatment. These disorders denote a set of persistent conditions that result in inflammation of the gastrointestinal tract. They cause inflammation and damage anywhere in the digestive system, starting from the mouth up till the anus. The treatment for Crohn’s disease acts by reducing the inflammation in the intestine, thus preventing symptom flare-ups and maintaining patient remission. To illustrate, in September 2023, data from the National Center for Biotechnology Information, a U.S. government agency, showed an upswing in the prevalence of both Crohn’s disease and ulcerative colitis. The projected figures for inflammatory bowel disease were set at 825 cases per 100,000 people in 2023—410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. Therefore, the upsurge in these disorders is contributing to the growth of the market for Crohn’s disease treatment.
What are the market segments in the crohn’s disease treatment industry?
The crohn’s disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics
2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates
3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids
4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine
5) By Other Drug Types: Biologics, Small Molecules, Other Treatments
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Which leading companies are shaping the growth of the crohn’s disease treatment market?
Major companies operating in the crohn’s disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.
What key trends are currently impacting the crohn’s disease treatment market’s development?
Leading businesses in the crohn’s disease treatment market are introducing novel drugs and gaining their approval, like the biosimilar ustekinumab, to offer better and more accessible treatment alternatives for patients, ultimately enhancing patient outcomes and life quality. Biosimilar ustekinumab is a biologic drug that is closely akin to the original ustekinumab (a monoclonal antibody) employed to treat autoimmune disorders. For example, Sandoz International GmbH, a pharmaceutical firm based in Switzerland, unveiled Pyzchiva (ustekinumab) throughout Europe in July 2024. This marked the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically for Crohn’s disease, providing treatment for adults and children over six suffering from plaque psoriasis, psoriatic arthritis, and Crohn’s disease. This expands Sandoz’s immunology offerings and aims to enhance access to cost-effective treatments for chronic inflammatory disease.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10852
Which geographic areas are influencing the growth of the crohn’s disease treatment market?
North America was the largest region in the global Crohn’s disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
End Stage Renal Disease (ESRD) Drug Global Market Report 2024
Enteric Disease Testing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report
Alzheimer’s Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
